On June 3, 2026, a Phase 4 clinical trial associated with sermorelin research was listed as recruiting. The study, registered as NCT06701071, is titled "Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation." According to the registry, the trial is currently in the recruiting stage. The listing identifies the study phase as Phase 4, indicating it involves further evaluation of an already available treatment approach. No results have been posted for this trial as of the event date. The registry entry does not provide additional details on outcomes, findings, or safety data at this time. This update reflects only the recruitment status and trial design as recorded in the public registry. Readers interested in sermorelin should note that this trial update pertains to a study protocol involving Clomid for ovarian stimulation, not a direct sermorelin trial. Regulatory status for sermorelin remains classified as unapproved for research use only. For general background on sermorelin, readers can consult the compound overview page.
Sermorelin-Linked Trial: Long vs Short Clomid Protocol Update
See the full sermorelin overview
Source: https://clinicaltrials.gov/study/NCT06701071